NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …

European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …

The ‘inherent design flaws’ of the human heart could become a thing of the past as new 3D printing technology …

Contract manufacturing organisation Cobra Biologics has hired Dr Daniel Smith as its chief scientific officer. Smith has spent the last …

Incentives are urgently required to speed up the development of personalised medicines, according to a new report from the Royal …

Contract research organisation (CRO) ICON has appointed Dr Hugh Brady as a non-executive director. Brady previously served as president at …

Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …
Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …
American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …

Comms consultancy firm Triducive has expanded with the appointment of a new senior account manager in Lucy Hannagan. Hannagan joins …

A former boss of AstraZeneca has warned that he fears Pfizer “will act like a praying mantis and suck the …

An Indian court has stopped the sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries after concerns were raised over insider …

Apple has headhunted a number of leading healthcare tech experts, sparking rumours that the firm is poised to make a …

Pfizer has attempted to enlist the help of UK prime minister David Cameron in its campaign to buy AstraZeneca, offering …

When something is not working – at least not as well as is expected – it is very tempting to …

Clinical research organisation (CRO) INC Research has promoted Jonathan Shough to the position of chief information officer. In this role …
Contract manufacturing organisation WuXi PharmaTech has begun work on a new facility in Philadelphia’s Navy Yard for the production of …

Cello Health that came to being in February following the combination of its Group agencies into one brand, has launched …

Bayer is in talks with Merck & Co to buy its consumer business and is willing to pay $14 billion …